IPCALAB2023-04-012023-06-30 IPCALAB2023-04-012023-06-30in-bse-fin:OneOperatingExpenses01Member IPCALAB2023-06-30 IPCALAB2023-04-012023-06-30in-bse-fin:OneItemsThatWillNotBeReclassifiedToProfitAndLoss01Member IPCALAB2023-04-012023-06-30in-bse-fin:OneItemsThatWillNotBeReclassifiedToProfitAndLoss02Member IPCALAB2023-04-012023-06-30in-bse-fin:OneItemsThatWillBeReclassifiedToProfitAndLoss01Member iso4217:INRxbrli:purexbrli:sharesiso4217:INRxbrli:shares 524494 IPCALAB NOTLISTED IPCA Laboratories Limited Equity 2023-04-01 2024-03-31 2023-08-10 2023-07-21 INR Crores First quarter 11:15:00 13:00:00 2023-08-10 2023-08-10 Not applicable Single segment Pharmaceuticals 2023-04-01 2023-06-30 Unaudited Consolidated 15875800000.00 448500000.00 16324300000.00 4324200000.00 1210900000.00 -381800000.00 3575100000.00 313800000.00 692700000.00 4071200000.00 13806100000.00 2518200000.00 0.00 2518200000.00 831400000.00 24700000.00 856100000.00 0.00 1662100000.00 0.00 0.00 0.00 -21100000.00 1641000000.00 -12400000.00 1628600000.00 1628200000.00 12800000.00 1615800000.00 12800000.00 253700000.00 1 6.42 6.42 0.00 0.00 6.42 6.42 Other expenses 4071200000.00 Actuarial gain/(loss) -5000000.00 Share of OCI from investment in associates -100000.00 -5100000.00 -1500000.00 Exchange difference in translating the financial statement of foreign operation -9400000.00 -9400000.00 -600000.00